Fetal Haemoglobin Variation Across Reported Crisis-Frequency Categories Among Sickle Cell Disease Patients in Ilorin, Nigeria: a Cross-Sectional Study

Authors

  • Abdulwaheed Adewale Ademosun Al-Hikmah University image/svg+xml
  • Abdullahi Olaleye Olawuyi Federal University of Health Sciences Ila-orangun
  • Halima Abubakar Abdulmalik Al-Hikmah University image/svg+xml
  • Adesina Tijani Busira Fountain University image/svg+xml
  • Luqman Olayinka Olatunbosun Al-Hikmah University image/svg+xml
  • Nuryn Abdulganiy
  • Musa Abidemi Muhibi Federal University of Health Sciences, Ila-Orangun image/svg+xml

DOI:

https://doi.org/10.33003/

Keywords:

fetal haemoglobin; sickle cell disease; crisis frequency; haemoglobin profile; high-performance liquid chromatography; Nigeria

Abstract

Background: Sickle cell disease is clinically heterogeneous, and fetal haemoglobin (HbF) is an important modifier of disease expression. Evidence linking HbF concentration with crisis frequency is not uniform across populations.

Objective: To determine whether HbF levels varied across reported crisis-frequency categories among patients with sickle cell disease attending the University of Ilorin Teaching Hospital, Ilorin, Nigeria.

Methods: A cross-sectional study included 44 patients with sickle cell disease attending the Haematology Clinic of the University of Ilorin Teaching Hospital from July to September 2023. Participants comprised 36 patients with HbSS and 8 with HbSC. Venous blood collected into EDTA was analyzed using a Bio-Rad D-10 haemoglobin analyzer. HbF, HbA2, HbA, HbA1c and HbS were quantified. Participants were classified by reported crisis frequency as annual, biannual, monthly, quarterly or weekly. Data were analyzed using IBM SPSS Statistics version 25.0, with one-way analysis of variance and chi-square tests.

Results: Mean HbF was 6.33 ± 3.24% overall, and was 10.70 ± 3.22% among participants reporting annual crises, 8.20 ± 2.40% for biannual, 5.47 ± 3.24% for monthly, 5.86 ± 3.01% for quarterly and 5.13 ± 3.00% for weekly crises. HbF differed significantly across categories (p = 0.047). HbA1c, HbA2, HbA and HbS did not differ significantly across categories.

Conclusion: Higher HbF concentrations were observed among participants reporting less frequent crises.

References

Adekile, A. (2021). The genetic and clinical significance of fetal hemoglobin expression in sickle cell disease. Medical Principles and Practice, 30(3), 201-211. https://doi.org/10.1159/000511342

Adeodu, O. O., Akinlosotu, M. A., Adegoke, S. A., & Oseni, S. B. A. (2017). Foetal haemoglobin and disease severity in Nigerian children with sickle cell anaemia. Mediterranean Journal of Hematology and Infectious Diseases, 9(1), e2017063. https://doi.org/10.4084/MJHID.2017.063

Adeyemo, T. A., Ojewunmi, O. O., Oyetunji, I. A., Rooks, H., Rees, D. C., Akinsulie, A. O., Akanmu, A. S., Thein, S. L., & Menzel, S. (2018). A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia. PLOS ONE, 13(6), e0197927. https://doi.org/10.1371/journal.pone.0197927

Amuzu, E. X., Urio, F., Dogbe, E. E., Ponsian, P., Abubakar, S. Y., Okeke, C., Balogun, O. O., Ozumba, P. J., Osei-Akoto, A., Paintsil, V., Nnodu, O., Balandya, E., Makani, J., Anazoeze, M., Ansong, D., & Nkya, S. (2025). Clinical manifestations of sickle cell disease in Africa and its association with foetal haemoglobin parameters. Communications Medicine, 5, 238. https://doi.org/10.1038/s43856-025-00954-z

Eneh, C. I., Nwankwo, C. A., & Nwaezike-Okafor, C. J. (2023). High performance liquid chromatographic pattern of children with sickle cell anaemia in Enugu Nigeria. International Journal of Tropical Disease & Health, 44(7), 23-30. https://doi.org/10.9734/IJTDH/2023/v44i71419

Fasola, F. A., Babalola, O. A., Brown, B. J., Odetunde, A., Falusi, A. G., & Olopade, O. (2022). The effect of alpha thalassemia, HbF and HbC on haematological parameters of sickle cell disease patients in Ibadan, Nigeria. Mediterranean Journal of Hematology and Infectious Diseases, 14(1), e2022001. https://doi.org/10.4084/MJHID.2022.001

Gallo, V., Egger, M., McCormack, V., Farmer, P. B., Ioannidis, J. P. A., Kirsch-Volders, M., Matullo, G., Phillips, D. H., Schoket, B., Stromberg, U., Vermeulen, R., Wild, C., Porta, M., & Vineis, P. (2011). STrengthening the Reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement. PLoS Medicine, 8(10), e1001117. https://doi.org/10.1371/journal.pmed.1001117

Isa, H., Adegoke, S., Madu, A., Hassan, A.-A., Ohiaeri, C., Chianumba, R., Brown, B., Okocha, E., Ugwu, N., Diaku-Akinwumi, I., Adeyemo, T., Kuliya-Gwarzo, A., Dogara, L., Lawal, H., Tanko, Y., Ladu, A., Kangiwa, U., Ekwem, L., Oniyangi, S., ... Nnodu, O. (2020). Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database. Blood Cells, Molecules, and Diseases, 84, 102438. https://doi.org/10.1016/j.bcmd.2020.102438

Kahema, S. E., Mbulwa, C. H., Bagenda, C. N., Niyonzima, N., & Muwanguzi, E. (2024). Association between fetal hemoglobin, lactate dehydrogenase, and disease severity in patients with sickle cell disease at Bugando Medical Centre, Mwanza, Tanzania. PLOS ONE, 19(7), e0286891. https://doi.org/10.1371/journal.pone.0286891

Morrice, J., Mupfururirwa, W., Chianumba, R. I., Amuzu, E. X., Kandonga, D., Nembaware, V., Jonas, M., Hotchkiss, J., Masamu, U., Nguweneza, A., Mmbando, B. P., Minja, I., Jonathan, A., Mulder, N., Balandya, E., Osei-Akoto, A., Paintsil, V., Makani, J., Nnodu, O., ... Wonkam, A. (2025). Sickle cell disease in Africa: SickleInAfrica Registry in Ghana, Nigeria and Tanzania. eJHaem, 6(3), e70044. https://doi.org/10.1002/jha2.70044

Ojewunmi, O. O., Adeyemo, T. A., Oyetunji, A. I., Inyang, B., Akinrindoye, A. A., Mkumbe, B. S., Gardner, K., Rooks, H., Brewin, J., Patel, H., Lee, S. H., Chung, R., Rashkin, S., Kang, G., Chianumba, R., Sangeda, R., Mwita, L., Isa, H., Agumadu, U.-N., ... Menzel, S. (2024). The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria. Human Molecular Genetics, 33(10), 919-929. https://doi.org/10.1093/hmg/ddae014

Okocha, E. C., Gyamfi, J., Ryan, N., Babalola, O., Etuk, E.-A., Chianumba, R., Nwegbu, M., Isa, H., Madu, A. J., Adegoke, S., Nnebe-Agumandu, U., Brown, B., Peprah, E., & Nnodu, O. E. (2022). Barriers to therapeutic use of hydroxyurea for sickle cell disease in Nigeria: A cross-sectional survey. Frontiers in Genetics, 12, 765958. https://doi.org/10.3389/fgene.2021.765958

Quinn, C. T., Niss, O., Dong, M., Pfeiffer, A., Korpik, J., Reynaud, M., Bonar, H., Kalfa, T. A., Smart, L. R., Malik, P., Ware, R. E., Vinks, A. A., & McGann, P. T. (2021). Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia. British Journal of Haematology, 194(3), 617-625. https://doi.org/10.1111/bjh.17663

Sales, R. R., Nogueira, B. L., Tosatti, J. A. G., Gomes, K. B., & Luizon, M. R. (2022). Do genetic polymorphisms affect fetal hemoglobin (HbF) levels in patients with sickle cell anemia treated with hydroxyurea? A systematic review and pathway analysis. Frontiers in Pharmacology, 12, 779497. https://doi.org/10.3389/fphar.2021.779497

Santos, G. P. dos, Rabi, L. T., Bezerra, A. A., Cunha, M. R. da, Iatecola, A., & Fernandes, V. A. R. (2024). Transcriptional regulators of fetal hemoglobin. Hematology, Transfusion and Cell Therapy, 46(Suppl 5), S258-S268. https://doi.org/10.1016/j.htct.2024.06.001

Serjeant, G. (2022). Phenotypic variation in sickle cell disease: The role of beta globin haplotype, alpha thalassemia, and fetal hemoglobin in HbSS. Expert Review of Hematology, 15(2), 107-116. https://doi.org/10.1080/17474086.2022.2040984

Steinberg, M. H. (2020). Fetal hemoglobin in sickle cell anemia. Blood, 136(21), 2392-2400. https://doi.org/10.1182/blood.2020007645

von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Medicine, 4(10), e296. https://doi.org/10.1371/journal.pmed.0040296

Ware, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017). Sickle cell disease. The Lancet, 390(10091), 311-323. https://doi.org/10.1016/S0140-6736(17)30193-9

Wastnedge, E., Waters, D., Patel, S., Morrison, K., Goh, M. Y., Adeloye, D., & Rudan, I. (2018). The global burden of sickle cell disease in children under five years of age: A systematic review and meta-analysis. Journal of Global Health, 8(2), 021103. https://doi.org/10.7189/jogh.08.021103

Fetal Haemoglobin Variation Across Reported Crisis-Frequency Categories Among Sickle Cell Disease Patients in Ilorin, Nigeria: a Cross-Sectional Study

Downloads

Published

17-11-2026

How to Cite

Ademosun, A. A., Olawuyi, A. O., Abdulmalik, H. A., Busira, A. T., Olatunbosun, L. O., Nuryn, A., & Muhibi, M. A. (2026). Fetal Haemoglobin Variation Across Reported Crisis-Frequency Categories Among Sickle Cell Disease Patients in Ilorin, Nigeria: a Cross-Sectional Study. FUDMA Journal of Sciences, 10(23), 277-283. https://doi.org/10.33003/

Most read articles by the same author(s)